OptimizeRx Corp
Public company- Headquarters
- WALTHAM, Massachusetts
- Ticker
- OPRX
- CIK
- 0001448431
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOEdward Stelmakh | Aug 12, 2026 | Departed |
| CFOAndrew D’Silva | Aug 12, 2026 | Appointed |
| Chief Accounting OfficerHeather Favazza | Aug 12, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Flywire Corp
member of the Board departs: Alex Finkelstein
- CONDUENT Inc
WARN notice: Newark, NJ
- Datavault AI Inc.
CEO departs: Nathaniel Bradley
- Uber Technologies, Inc
President and Chief Corporate Affairs Officer departs: Jill Hazelbaker
- Executive departure
CFO departs: Edward Stelmakh
Edward Stelmakh, Chief Financial & Strategy Officer of OptimizeRx Corp, departs the role, effective December 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 12, 2026Role: Chief Financial & Strategy Officer
- Executive appointment
CFO appointed: Andrew D’Silva
Andrew D’Silva was named Chief Financial Officer of OptimizeRx Corp, effective January 1, 2027. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 12, 2026Role: Chief Financial Officer
- Executive appointment
Chief Accounting Officer appointed: Heather Favazza
Heather Favazza was named Chief Accounting Officer of OptimizeRx Corp, effective January 1, 2027. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 12, 2026Role: Chief Accounting Officer
Last verified Nov 8, 2026